Pembrolizumab Solid Formulation

Hazard statements (CLP)

H360D, H372

Code

Statements

H360D

May damage the unborn child

SECTION 2: Hazards identification

GHS Classification Manufacture, Storage and Import of Hazardous Chemicals Rules 1989 Classification Not classified as hazardous according to criteria laid down in Part I of Schedule-1 GHS Classification Reproductive toxicity Category 1B Specific target organ toxicity - repeated exposure (Oral) Category 1 (Immune system)

Signal word

Danger

Hazard statements

H360D May damage the unborn child. H372 Causes damage to organs (Immune system) through prolonged or repeated exposure if swallowed.

Prevention

P203 Obtain, read and follow all safety instructions before use. P260 Do not breathe dust. P264 Wash hands thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.

Response

P318 IF exposed or concerned, get medical advice.

Storage

P405 Store locked up.

Disposal

P501 Dispose of contents/ container to an approved waste disposal plant.

Other hazards which do not result in classification

Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin. May form explosive dust-air mixture during processing, handling or other means.

2.1 Classification of the substance or mixture

Not classified as hazardous according to criteria laid down in Part I of Schedule-1. GHS Classification Reproductive toxicity : Category 1B Specific target organ toxicity - : Category 1 (Immune system) repeated exposure (Oral)